Closed tender

NHS England procurement for the supply of pangenotypic Hepatitis C treatments

Details

Buyer
NHS England
Published
19 December 2025
Submission
6 February 2026
Source
uk:atamis:dhsc

Tender description

NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives commencing 1st April 2026

Timeline

  1. Tender published19 December 2025
    Current notice
  2. Submission date6 February 2026

About the buyer

NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

Related buyers

Buyers similar to NHS England.

View all buyers
BuyersCountValue
  1. NHS Property Services Ltd
    445
    £233.2m
  2. UK Shared Business Services - UKSBS
    364
    £249.1m
  3. Sellafield Limited
    350
    £15.0bn
  4. Bank of England
    290
    £2.8bn
  5. Network Rail
    257
    £18.2bn
  6. Department of Health and Social Care
    251
    £890.6m
  7. Financial Conduct Authority
    241
    £508.7m
  8. Post Office Ltd
    201
    £1.0bn
  9. Nuclear Decommissioning Authority (NDA)
    139
    £895.4m
  10. Genomics England
    114
    £59.4m

Win more public sector contracts

Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.

Try for free